Answer
Ustekinumab is contraindicated in hypersensitivity to ustekinumab or any excipient, and in clinically important active infection, such as active tuberculosis.
Sources for this answer
- STELARA 130 mg concentrate for solution for infusionJanssen-Cilag Ltd (a Johnson & Johnson Company) · emc · SmPC §4.3 Contraindications · Version 25Document updated
Sources checked